new glp-1 drug retatrutide Retatrutide: The Future of Weight Management Retatrutide vs Tirzepatide (2026): Differences

doi: 10.1074/jbc.M111.310342 28 KosiborodMNAbildstrmSZBorlaugBAButlerJRasmussenSDaviesMet al

Preliminary mechanistic investigations suggest that GLP-1 medicines exert direct anti-inflammatory effects, reducing biomarkers such as C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-)

The method used in the study is not the gold standard scintigraphy that involves radioactive tracers, and the researchers did not take into account secretion-based error [40]

Retatrutide is a synthetic peptide acting as an agonist of GLP-1, GIP, and glucagon receptors (Figure 1)

Switching from semaglutide to tirzepatide Switching from Ozempic to Mounjaro or Wegovy to Zepbound is possible when done under the guidance of a healthcare provider

Medications such as semaglutide and liraglutide have been noted to provide benefits, including improved glycemic control, weight loss, and a reduction in cardiovascular risk